Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer

@article{Lu2018PrognosticIO,
  title={Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer},
  author={Hai-Min Lu and Wanying Yi and Yushui Ma and Wei Wu and Fei Yu and Hengwei Fan and Zhongwei Lv and Huiqiong Yang and Zhengyan Chang and Chao Zhang and Wenting Xie and Jun-jian Jiang and Ying Song and Li Chai and Cheng-You Jia and Gaixia Lu and Xiaojun Zhong and Likun Hou and Chun-yan Wu and Min-Xin Shi and Jibin Liu and Da Fu},
  journal={Oncology Letters},
  year={2018},
  volume={16},
  pages={7048 - 7056}
}
To investigate the expression level of microRNA-101-3p (miR-101-3p) and its possible association with progression, prognosis and chemotherapy in patients with non-small cell lung cancer (NSCLC), the Gene Expression Omnibus (GEO) database was used. Quantitative polymerase chain reaction was used to verify the expression in 327 NSCLC and 42 adjacent normal lung tissues, of which 42 viable tissues were paired with nearby normal lung tissues. Based on the Cox regression model, univariate and… 
View PDF
11 Citations
Background Citations
4

Figures and Tables from this paper

11 Citations

Citation Type

Citation Type

Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma
miR-101-3p sensitizes non-small cell lung cancer cells to irradiation
Abstract Recent studies have revealed that microRNAs regulate radiosensitivity of non-small cell lung cancer (NSCLC). The aim of this study was to investigate whether miR-101-3p is correlated with…
MicroRNA in Lung Cancer Metastasis
TLDR
The current research related to the role of miRNAs in lung cancer invasion and metastasis is discussed, with a particular focus on the different metastatic lesions and potential miRNA-targeted treatments for lung cancer with the expectation that further exploration of mi RNA- targeted therapy may establish a new spectrum of lung cancer treatments.
Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression
TLDR
It is demonstrated that circZFR exhibited a carcinogenic role by sponging miR-101-3p and regulating CUL4B expression in NSCLC and acted as a sponge to absorb microRNAs and promote cullin 4B expression.
MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2
TLDR
Overall, microRNA-101-3p/KPNA2 axis can play an important part in progression of cervical squamous cell carcinoma.
Exploring the ‘Dormancy Activation Switch’ in the Tumour Microenvironment for Metastatic Lung Cancer: The Possible Role of MicroRNA
TLDR
This chapter will review the major cellular signalling pathways that promote the proliferation and metastasis of lung cancer cells to each of these metastatic sites, hopefully to shine the light on the possible therapeutic targets that could be developed against these pathways for better therapeutic outcome.
miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1.
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM
Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma
TLDR
In silico results showed a potential prognostic role of hsa-miR-101-3p due to a significant association of its higher expression and increased overall survival (OS) of MM patients, and receiver operating characteristic (ROC) analysis revealed high specificity and sensitivity rates for both hsa and hsa, which acquire a diagnostic value for MM.
miRNA-101 Regulates Filamentogenesis During Migration and Invasion of Cervical Cancer Cells
TLDR
It is indicated that miRNA-101 inhibits CC migration and invasion by analysing the formation of filamentous pseudopodia and will help provide a theoretical basis and novel insight for the clinical management of CC.
...
...

References

SHOWING 1-10 OF 41 REFERENCES
Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer
TLDR
Reduced miR-105-1 expression in NSCLC tissues is associated with poor OS and disease-free survival of patients, and multivariate survival analysis demonstrated that reduced miR -105- 1 expression and tumor size were independent predictors for OS of NS CLC patients.
Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy
TLDR
It is implied that miR-33a expression levels may have an essential role in NSCLC progression, and could act as a specific and sensitive biomarker forNSCLC patients who have undergone adjuvant chemotherapy.
MicroRNA-125a-3p downregulation correlates with tumorigenesis and poor prognosis in patients with non-small cell lung cancer
TLDR
High expression levels of miR-125a-3p with chemotherapy prolonged the overall survival rate and disease free survival rate compared with untreated patients with low expression ofMiR- 125a- 3p, which is a significant prognostic biomarker for patients with NSCLC.
High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1
TLDR
ITGB1 and miR-493-5p may have potential prognostic value and may be useful as tumor biomarkers for the diagnosis of NSCLC patients and provide the first evidence that ITGB1 is a direct target of miR -493- 5p.
High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1
TLDR
The results provide the first evidence that NCOA1 is a direct target of miR-105-1 suggesting that N COA1 andmiR- 105-1 may have potential prognostic value and may be useful as tumor biomarkers for the diagnosis of HCC patients.
MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
TLDR
Overall and progression-free survival time was decreased in patients expressing low miR-33a with multiple tumor foci, suggesting that the low expression of miR -33a may be a potential risk factor for HCC.
Up-regulated microRNA-299 corrected with poor prognosis of glioblastoma multiforme patients by targeting ELL2
TLDR
Increased ELL2 expression and down-regulation of miR-299 are associated with GBM progression and poor prognosis in patients, suggesting that ELL1 and miR -299 might have potential prognostic value and be used as tumor biomarkers for the diagnosis of patients with G BM.
SIRT1 Expression Is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
TLDR
The data suggest that the SIRT1 expression may be a molecular marker associated with the NSLCLC clinical features, treatment responsiveness and prognosis of advanced NSCLC.
Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells
TLDR
It is suggested that miR-101 acts as a novel suppressor by targeting the Rac1 gene and inhibiting thyroid cancer cell migration and invasion.
Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
...
...